an oral sphingosine 1-phosphate (S1P) receptor modulator approved in 2021, as well as AbbVie’s JAK inhibitor (and Skyrizi sister med) Rinvoq. Pfizer’s Zeposia rival Velsipity, also an S1P ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Fully automated pipeline allows for 500.000 binding energy predictions per month to speed up in silico enzyme and inhibitor screening and discovery projects GELEEN, NETHERLANDS, October 31 ...

Inavolisib joins Novartis’s first-in-class phosphatidylinositol 3-kinase (PI3K) inhibitor alpelisib on the market, but adds a monomeric degrader mechanism of action that could expand its utility.

V has planned to treat his fans to a special surprise this Thanksgiving. On Friday, November 22, V, currently serving in mandatory military service, surprised BTS ARMY by announcing his upcoming ...

Sanofi lifts lid on MS data behind tolebrutinib’s mixed phase 3 scorecard, plans ‘24 approval filings Rilzabrutinib is an oral inhibitor of Bruton’s tyrosine kinase (BTK), a protein that ...

Despite winning an alopecia areata approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to launch its JAK inhibitor competitor to Eli Lilly and Incyte’s Olumiant ...

Tuesday is Nov. 5 – the perfect night to rewatch V for Vendetta. This year, the acclaimed movie is streaming on Prime Video for all subscribers. You can also find a hard copy of the movie ...

The term “protease inhibitor” refers to a class of medications rather than to a single medication. Specifically, they are antiviral drugs. But unlike the many, more common antiviral drugs that ...

Also known as selective COX-2 inhibitors, these medications treat inflammatory pain. Selective COX-2 inhibitors are a type of nonsteroidal anti-inflammatory medication (also known as NSAIDs).